✦ LIBER ✦

Prolonged oral etoposide in combination with intravenous cisplatin (oral EP) for non-small cell lung cancer (NSCLC)

✍ Scribed by Park, K; Kim, K; Jeong, HS; Lee, JT; Kim, WS; Yoon, SS; Kang, WK; Lee, HG; Kim, H; Rhee, CH; Park, CH

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of prolonged oral etoposi

✍ Miller, Antonius A.; Niell, Harvey B.; Griffin, John P. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 473 KB

Phase II study of prolonged oral etoposi

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Clinical and pharmacological phase II st

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Prolonged oral versus high-dose intraven

✍ Jeremic, Branislav; Shibamoto, Yuta; Milicic, Biljana; Milisavljevic, Slobodan; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Chronic daily administration of oral eto

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Taxol and cisplatin (TP) versus etoposid

✍ T.E. Ciuleanu; C. Cebotaru; I. Radulescu; N. Todor; N. Ghilezan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 317 KB